<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>2022</volume><submitter>Le PTQ</submitter><pubmed_abstract>&lt;i>SRD5A2&lt;/i> (steroid 5-alpha-reductase 2) mutation, which impairs 5&lt;i>α&lt;/i>-reductase-2 enzyme activity, is among the causes of 46,XY disorders of sex development (DSD). Here, we report a rare pathogenic mutation NM_000348.4:c.485A>C (NP_000339.2:p.His162Pro) of &lt;i>SRD5A2&lt;/i> gene in a compound heterozygous state first identified in a Vietnamese newborn with 5&lt;i>α&lt;/i>-reductase-2 enzyme deficiency. We also first submitted this rare mutation to ClinVar database (VCV000973099.1). The patient presented with hyperpigmented labia-majora-like bifid scrotum, clitoris-like phallus, perineoscrotal hypospadias, and blind-ending vagina. The other mutation NM_000348.4:c.680G>A (NP_000339.2:p.Arg227Gln) was reported previously. This compound heterozygous mutation was first detected by next-generation sequencing. By Sanger sequencing, we confirmed that the c.485A>C mutation was maternal inherited, whereas the c.680G>A mutation was paternal inherited. Up to date, this is the first report of this rare compound heterozygous state of &lt;i>SRD5A2&lt;/i> c.485A>C and c.680G>A mutations in patients with 46,XY DSD generally as well as in Vietnamese population particularly and is also the second report in the world carrying the pathogenic mutation NM_000348.4:c.485A>C (NP_000339.2:p.His162Pro). Our finding has enriched the understanding of the spectrum of &lt;i>SRD5A2&lt;/i> variants and phenotypic correlation in Asian patients with 46,XY DSD.</pubmed_abstract><journal>Case reports in endocrinology</journal><pagination>6025916</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8977313</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>An Extremely Rare &lt;i>SRD5A2&lt;/i> Gene c.485A>C Mutation in a Compound Heterozygous Newborn with Disorders of Sex Development First Identified in Vietnam.</pubmed_title><pmcid>PMC8977313</pmcid><pubmed_authors>Nguyen TTB</pubmed_authors><pubmed_authors>Ha TMT</pubmed_authors><pubmed_authors>Le PTQ</pubmed_authors><pubmed_authors>Nguyen MT</pubmed_authors><pubmed_authors>Le TNU</pubmed_authors></additional><is_claimable>false</is_claimable><name>An Extremely Rare &lt;i>SRD5A2&lt;/i> Gene c.485A>C Mutation in a Compound Heterozygous Newborn with Disorders of Sex Development First Identified in Vietnam.</name><description>&lt;i>SRD5A2&lt;/i> (steroid 5-alpha-reductase 2) mutation, which impairs 5&lt;i>α&lt;/i>-reductase-2 enzyme activity, is among the causes of 46,XY disorders of sex development (DSD). Here, we report a rare pathogenic mutation NM_000348.4:c.485A>C (NP_000339.2:p.His162Pro) of &lt;i>SRD5A2&lt;/i> gene in a compound heterozygous state first identified in a Vietnamese newborn with 5&lt;i>α&lt;/i>-reductase-2 enzyme deficiency. We also first submitted this rare mutation to ClinVar database (VCV000973099.1). The patient presented with hyperpigmented labia-majora-like bifid scrotum, clitoris-like phallus, perineoscrotal hypospadias, and blind-ending vagina. The other mutation NM_000348.4:c.680G>A (NP_000339.2:p.Arg227Gln) was reported previously. This compound heterozygous mutation was first detected by next-generation sequencing. By Sanger sequencing, we confirmed that the c.485A>C mutation was maternal inherited, whereas the c.680G>A mutation was paternal inherited. Up to date, this is the first report of this rare compound heterozygous state of &lt;i>SRD5A2&lt;/i> c.485A>C and c.680G>A mutations in patients with 46,XY DSD generally as well as in Vietnamese population particularly and is also the second report in the world carrying the pathogenic mutation NM_000348.4:c.485A>C (NP_000339.2:p.His162Pro). Our finding has enriched the understanding of the spectrum of &lt;i>SRD5A2&lt;/i> variants and phenotypic correlation in Asian patients with 46,XY DSD.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022</publication><modification>2025-06-01T01:11:54.63Z</modification><creation>2024-11-13T18:10:40.969Z</creation></dates><accession>S-EPMC8977313</accession><cross_references><pubmed>35386187</pubmed><doi>10.1155/2022/6025916</doi></cross_references></HashMap>